Stock Quote        
  Join        Login  
logo

IRIS International (IRIS) Sees 2012 GAAP EPS Between 30 Cents And 35 Cents

 December 02, 2011 09:02 AM
 

IRIS International Inc. (NASDAQ:IRIS) sees GAAP earnings per share between 30 cents and 35 cents on revenue in the range of $127 million to $131 million for 2012. 

The Chatsworth, California-based company manufactures in vitro diagnostic (IVD) products for urinalysis and body fluids.

Analysts, on average, expect the company to earn 39 cents per share on revenue of $128.89 million. Analysts' estimates typically exclude special items.

The company said earnings forecast includes the sales and marketing expense of a focused direct sales effort for its ProsVue cancer test.

IRIS expects research and development expense to represent 15 percent to 16 percent of revenue in 2012.
 
Last month, IRIS posted a third quarter GAAP loss per share of 24 cents on revenue of $28.1 million. The company Received 510(k) clearance from the FDA in September 2011 and CE Mark approval in October 2011 for its NADiA ProsVue prognostic prostate cancer test.
 
Shares of IRIS closed Thursday's regular trading at $9.73. The stock has been trading in the 52-week range between $7.73 and $10.65.

Rich
i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.

You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.

Two Week FREE Trial


Signup for i on the market daily edition


Advertisement

Comments Closed


Advertisement
Connect with iStockAnalyst
Popular Articles
Recent Research and Quote
Advertisement
Partner Center
Home | Login |Research | Earnings | Scans | Charts | Submit Article | Join Blog Network | Advertise | Subscribe to RSS

Terms of Use | Privacy Policy | Copryright 2013 all rights reserved



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.